• Info
  • Insider Ownership

Insider Trading & Ownership of Mark A. Meltz

Location
South San Francisco, CA
Signature
/s/ Mark Meltz, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Mark A. Meltz and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Mark A. Meltz has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Kinnate Biopharma Inc. ($0).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Mark A. Meltz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KNTE Kinnate Biopharma Inc. Coo General Counsel Secretary $0 03 Apr 2024
LYEL Lyell Immunopharma, Inc. General Counsel 10 Feb 2026

Insider Transactions Reported by Mark A. Meltz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored